{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:05:25Z","timestamp":1789095925826,"version":"build-2803163510"},"reference-count":35,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The Consortium on Newborn Screening in Africa (CONSA), launched by the American Society of Hematology in 2020, is designed to initiate and expand sustainable newborn screening (NBS) programs for sickle cell disease (SCD) across sub-Saharan Africa. This multiyear pilot program includes 11 clinical sites in 7 countries, namely Ghana, Kenya, Liberia, Nigeria, Tanzania, Uganda, and Zambia. After extensive training of laboratory and clinical personnel, dried blood spots were collected from newborns and tested by isoelectric focusing at central laboratories within each country. Positive samples were confirmed, and the affected infants were invited into clinical care for penicillin prophylaxis, malaria prevention, routine immunizations, and family education. As of November 2025, almost 175 000 samples have been collected and assessed. The overall prevalence of SCD was 1.46%, with the highest prevalence in Mwanza, Tanzania (2.00%). The majority of positive screening results were homozygous HbSS (81.5%), along with compound heterozygous HbSC (11.0%) and HbS\u03b2+ thalassemia (7.5%). Hemoglobin S trait was common throughout the countries with an average of 16.17%, whereas hemoglobin C trait had an incidence of 1.59% and was found primarily in Ghana and Nigeria. Additional hemoglobin variants were also detected in several countries. Confirmatory samples have been documented in about one-third of infants with a positive screening result, with 87.8% of those confirmed to have SCD. Fewer than half of the affected infants have documented clinical follow-up at CONSA sites for various logistical and financial reasons. CONSA has made great strides in promoting NBS for SCD in sub-Saharan Africa, but gaps in the confirmatory testing and enrollment into clinical care persist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019796","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:52:58Z","timestamp":1773251578000},"page":"3200-3206","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA)"],"prefix":"10.1182","volume":"10","author":[{"given":"Bernard O.","family":"Awuonda","sequence":"first","affiliation":[{"name":"1Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kiyaga","sequence":"additional","affiliation":[{"name":"2Central Public Health Laboratories, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chirande","sequence":"additional","affiliation":[{"name":"3Muhimbili National Hospital, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patience C.","family":"Franklin","sequence":"additional","affiliation":[{"name":"4John F. Kennedy Medical Center, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4801-3156","authenticated-orcid":false,"given":"Obiageli E.","family":"Nnodu","sequence":"additional","affiliation":[{"name":"5Department of Haematology and Blood Transfusion, University of Abuja, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuela E.","family":"Ambrose","sequence":"additional","affiliation":[{"name":"6Haematology Section, Paediatric Department, Bugando Medical Centre, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-6512","authenticated-orcid":false,"given":"Livingstone G.","family":"Dogara","sequence":"additional","affiliation":[{"name":"7Kaduna State University, Kaduna, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-4933","authenticated-orcid":false,"given":"Catherine M.","family":"Chunda-Liyoka","sequence":"additional","affiliation":[{"name":"8University Teaching Hospitals, Children\u2019s Hospital, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine I.","family":"Segbefia","sequence":"additional","affiliation":[{"name":"9University of Ghana Medical School, Accra, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Zapfel","sequence":"additional","affiliation":[{"name":"10American Society of Hematology, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-1156","authenticated-orcid":false,"given":"Marie-Ana\u00efs","family":"Benoit","sequence":"additional","affiliation":[{"name":"10American Society of Hematology, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Odame","sequence":"additional","affiliation":[{"name":"11Division of Hematology, Toronto Sick Kids, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ven\u00e9e N.","family":"Tubman","sequence":"additional","affiliation":[{"name":"12Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen Okam","family":"Achebe","sequence":"additional","affiliation":[{"name":"13Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-8103","authenticated-orcid":false,"given":"Alexis A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"14Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S.","family":"Green","sequence":"additional","affiliation":[{"name":"15Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Berliner","sequence":"additional","affiliation":[{"name":"13Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8285","authenticated-orcid":false,"given":"Enrico M.","family":"Novelli","sequence":"additional","affiliation":[{"name":"16Division of Classical Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L.","family":"Coetzer","sequence":"additional","affiliation":[{"name":"17University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9582-0594","authenticated-orcid":false,"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[{"name":"18Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"10091","key":"2026050815182611200_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"9861","key":"2026050815182611200_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"2026050815182611200_bib3","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"issue":"7","key":"2026050815182611200_bib4","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLos Med"},{"issue":"3","key":"2026050815182611200_bib5","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2214-109X(15)00288-0","article-title":"Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study","volume":"4","author":"Ndeezi","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"10","key":"2026050815182611200_bib6","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1016\/S2352-3026(21)00216-7","article-title":"Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 Demographic and Health Survey","volume":"8","author":"Nnodu","year":"2021","journal-title":"Lancet Haematol"},{"issue":"3","key":"2026050815182611200_bib7","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2352-3026(22)00004-7","article-title":"Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study","volume":"9","author":"Ranque","year":"2022","journal-title":"Lancet Haematol"},{"issue":"2","key":"2026050815182611200_bib8","doi-asserted-by":"crossref","first-page":"e14699","DOI":"10.1371\/journal.pone.0014699","article-title":"Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania","volume":"6","author":"Makani","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"2026050815182611200_bib9","doi-asserted-by":"crossref","first-page":"e1458","DOI":"10.1016\/S2214-109X(19)30328-6","article-title":"The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study","volume":"7","author":"Uyoga","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"8","key":"2026050815182611200_bib10","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission","volume":"10","author":"Piel","year":"2023","journal-title":"Lancet Haematol"},{"issue":"2","key":"2026050815182611200_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin Perinatol"},{"issue":"3","key":"2026050815182611200_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semperi.2015.03.008","article-title":"Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol"},{"issue":"7","key":"2026050815182611200_bib13","first-page":"648","article-title":"Evaluation of newborn sickle cell screening programme in England: 2010-2016","volume":"103","author":"Streetly","year":"2018","journal-title":"Arch Dis Child"},{"issue":"4","key":"2026050815182611200_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/bjh.15600","article-title":"Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference","volume":"183","author":"Lobitz","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"2026050815182611200_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jha2.926","article-title":"Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: a retrospective cohort study","volume":"5","author":"Kazadi","year":"2024","journal-title":"EJHaem"},{"issue":"8","key":"2026050815182611200_bib16","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/S2352-3026(23)00205-3","article-title":"Sickle cell disease in the Caribbean: progress in newborn screening, clinical care, and research through collaboration","volume":"10","author":"Knight-Madden","year":"2023","journal-title":"Lancet Haematol"},{"issue":"6","key":"2026050815182611200_bib17","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.pcl.2013.09.006","article-title":"Sickle cell disease in childhood: from newborn screening through transition to adult medical care","volume":"60","author":"Quinn","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"2026050815182611200_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jcp.2008.058958","article-title":"Neonatal screening for sickle anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns","volume":"62","author":"Tshilolo","year":"2009","journal-title":"J Clin Pathol"},{"issue":"12","key":"2026050815182611200_bib19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ajh.23578","article-title":"A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola","volume":"88","author":"McGann","year":"2013","journal-title":"Am J Hematol"},{"issue":"4","key":"2026050815182611200_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/pbc.25875","article-title":"Newborn screening for sickle cell disease in Liberia: a pilot study","volume":"63","author":"Tubman","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2026050815182611200_bib21","doi-asserted-by":"crossref","first-page":"e29068","DOI":"10.1002\/pbc.29068","article-title":"Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: results and lessons learned","volume":"68","author":"Segbefia","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"24","key":"2026050815182611200_bib22","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1182\/bloodadvances.2022007698","article-title":"The Consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology","volume":"6","author":"Green","year":"2022","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"2026050815182611200_bib23","doi-asserted-by":"crossref","first-page":"520a","DOI":"10.1182\/blood-2024-203142","article-title":"Building capacity in sub-Saharan Africa to address sickle cell disease: the Consortium on Newborn Screening in Africa (CONSA)","volume":"144","author":"Kiyaga","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2026050815182611200_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00286522","article-title":"Hemoglobins S and C in Upper Volta","volume":"65","author":"Labie","year":"1984","journal-title":"Hum Genet"},{"issue":"5","key":"2026050815182611200_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00209020","article-title":"Nucleotide sequencing evidence of the unicentric origin of the beta C mutation in Africa","volume":"87","author":"Trabuchet","year":"1991","journal-title":"Hum Genet"},{"issue":"1","key":"2026050815182611200_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/bloodadvances.2016000950","article-title":"Hemoglobin variants identified in the Uganda Sickle Surveillance Study","volume":"1","author":"Schaefer","year":"2016","journal-title":"Blood Adv"},{"issue":"1","key":"2026050815182611200_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijns10010022","article-title":"Current methods of newborn screening follow-up for sickle cell disease are highly variable and without quality assurance: results from the ENHANCE study","volume":"10","author":"Galadanci","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"2026050815182611200_bib28","doi-asserted-by":"crossref","first-page":"e20184105","DOI":"10.1542\/peds.2018-4105","article-title":"Newborn screening for sickle cell disease using point-of-care testing in low-income setting","volume":"144","author":"Alvarez","year":"2019","journal-title":"Pediatrics"},{"issue":"24","key":"2026050815182611200_bib29","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use of hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2026050815182611200_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N Engl J Med"},{"issue":"26","key":"2026050815182611200_bib31","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell anemia in sub-Saharan Africa","volume":"382","author":"John","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"2026050815182611200_bib32","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomized, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"},{"issue":"8","key":"2026050815182611200_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.2022016620","article-title":"Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial","volume":"141","author":"Abdullahi","year":"2023","journal-title":"Blood"},{"issue":"4","key":"2026050815182611200_bib34","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/S2352-3026(22)00405-7","article-title":"Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial","volume":"10","author":"Ambrose","year":"2023","journal-title":"Lancet Haematol"},{"issue":"6","key":"2026050815182611200_bib35","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(24)00078-4","article-title":"Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1\/2 trial","volume":"11","author":"Aygun","year":"2024","journal-title":"Lancet Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3200\/2516447\/blooda_adv-2026-019796-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3200\/2516447\/blooda_adv-2026-019796-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:18:36Z","timestamp":1778267916000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/9\/3200\/567142\/Newborn-screening-results-for-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019796","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,12]]},"published":{"date-parts":[[2026,5,1]]}}}